Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
7.57
+0.44 (6.17%)
Sep 8, 2026, 1:00 PM EDT - Market open
Entrada Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 4.69 | 5.74 | 25.42 | 61.52 | 79.48 | 172.22 | 210.78 | 215.23 | 239.4 | 162.87 | 129.01 | 87.17 | 43.43 | 25.26 | - | - | - | - | - | - | |
Revenue Growth (YoY) | -94.10% | -96.67% | -87.94% | -71.42% | -66.80% | 5.74% | 63.38% | 146.92% | 451.22% | 544.79% | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue | 139.04 | 141.55 | 140.57 | 141.72 | 134.61 | 128.77 | 125.31 | 120.19 | 111.13 | 105.39 | 99.88 | 87.28 | 84.05 | 73.99 | 66.61 | 86.85 | 67.89 | 51.64 | 35.93 | - |
Gross Profit | -134.36 | -135.81 | -115.15 | -80.2 | -55.14 | 43.45 | 85.48 | 95.04 | 128.27 | 57.48 | 29.13 | -0.11 | -40.62 | -48.73 | -66.61 | -86.85 | -67.89 | -51.64 | -35.93 | - |
Selling, General & Admin | 40.27 | 40.7 | 40.85 | 41.36 | 41.03 | 39.34 | 38.47 | 37.26 | 34.82 | 33.75 | 32.29 | 33.53 | 32.98 | 32.14 | 30.64 | 26.84 | 23.72 | 19.46 | 15.2 | 11.1 |
Research & Development | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -23.56 | -13.05 | -6.22 | - | 30.22 |
Operating Expenses | 40.27 | 40.7 | 40.85 | 41.36 | 41.03 | 39.34 | 38.47 | 37.26 | 34.82 | 33.75 | 32.29 | 33.53 | 32.98 | 32.14 | 30.64 | 3.28 | 10.67 | 13.24 | 15.2 | 41.32 |
Operating Income | -174.63 | -176.51 | -156 | -121.56 | -96.16 | 4.11 | 47.01 | 57.78 | 93.45 | 23.73 | -3.16 | -33.65 | -73.59 | -80.88 | -97.25 | -90.13 | -78.56 | -64.89 | -51.13 | -41.32 |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.04 |
Interest & Investment Income | 11.57 | 13.26 | 15.07 | 17.06 | 19.26 | 19.7 | 19.47 | 18.64 | 16.92 | 16.78 | 15.22 | 11.88 | 8.62 | 4.81 | 2.63 | 1.77 | 0.9 | 0.51 | 0.04 | 0.16 |
Other Non Operating Income (Expenses) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.16 |
EBT Excluding Unusual Items | -163.06 | -163.26 | -140.93 | -104.49 | -76.91 | 23.81 | 66.49 | 76.42 | 110.38 | 40.51 | 12.06 | -21.77 | -64.97 | -76.07 | -94.62 | -88.36 | -77.65 | -64.38 | -51.08 | -41.36 |
Merger & Restructuring Charges | -1.9 | -1.9 | -1.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.07 | -0.07 | -0.07 | -0.07 | -0.02 |
Pretax Income | -164.96 | -165.16 | -142.83 | -104.49 | -76.91 | 23.81 | 66.49 | 76.42 | 110.38 | 40.51 | 12.06 | -21.77 | -64.97 | -76.07 | -94.62 | -88.43 | -77.73 | -64.45 | -51.16 | -41.38 |
Income Tax Expense | 0.82 | 0.96 | 0.92 | -1.04 | -3.55 | -0.97 | 0.86 | 21.47 | 5.93 | 17.02 | 18.74 | - | 17.4 | 3.55 | - | - | - | - | - | - |
Net Income | -165.78 | -166.12 | -143.75 | -103.46 | -73.35 | 24.78 | 65.63 | 54.95 | 104.44 | 23.49 | -6.69 | -21.77 | -82.37 | -79.62 | -94.62 | -88.43 | -77.73 | -64.45 | -51.16 | -41.38 |
Net Income to Common | -165.78 | -166.12 | -143.75 | -103.46 | -73.35 | 24.78 | 65.63 | 54.95 | 104.44 | 23.49 | -6.69 | -21.77 | -82.37 | -79.62 | -94.62 | -88.43 | -77.73 | -64.45 | -51.16 | -41.38 |
Net Income Growth (YoY) | - | - | - | - | - | 5.52% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 42 | 42 | 41 | 41 | 41 | 39 | 37 | 35 | 34 | 33 | 33 | 33 | 32 | 32 | 31 | 29 | 21 | 14 | 6 | 1 |
Shares Outstanding (Diluted) | 42 | 42 | 41 | 41 | 41 | 41 | 39 | 36 | 34 | 34 | 33 | 33 | 32 | 32 | 31 | 29 | 21 | 14 | 6 | 1 |
Shares Change (YoY) | 1.93% | 2.44% | 6.07% | 15.95% | 19.72% | 20.56% | 18.01% | 9.14% | 6.84% | 6.59% | 5.62% | 13.36% | 50.79% | 129.38% | 399.27% | 2090.29% | 1632.69% | 1089.36% | 467.09% | - |
EPS (Basic) | -3.97 | -4.00 | -3.47 | -2.51 | -1.79 | 0.63 | 1.76 | 1.55 | 3.11 | 0.70 | -0.20 | -0.67 | -2.57 | -2.52 | -3.02 | -3.08 | -3.66 | -4.68 | -8.16 | -31.57 |
EPS (Diluted) | -3.97 | -4.00 | -3.47 | -2.52 | -1.79 | 0.60 | 1.68 | 1.55 | 3.04 | 0.70 | -0.20 | -0.67 | -2.57 | -2.53 | -3.02 | -3.08 | -3.66 | -4.68 | -8.16 | -31.58 |
EPS Growth (YoY) | - | - | - | - | - | -14.24% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -134.35 | -131.64 | -129.55 | -129.8 | -126.56 | -58.01 | -44.72 | -17.46 | -18.5 | -93.9 | 134.19 | 111.17 | 108.81 | 126.64 | -96.67 | -90.52 | -77.11 | -67.78 | -55.44 | -41.65 |
Free Cash Flow Per Share | -3.21 | -3.17 | -3.13 | -3.15 | -3.09 | -1.43 | -1.15 | -0.49 | -0.54 | -2.79 | 4.06 | 3.42 | 3.40 | 4.01 | -3.09 | -3.15 | -3.63 | -4.92 | -8.85 | -31.77 |
Gross Margin | - | - | - | -130.36% | -69.38% | 25.23% | 40.55% | 44.16% | 53.58% | 35.29% | 22.58% | -0.13% | -93.52% | -192.92% | - | - | - | - | - | - |
Operating Margin | -3726.53% | -3076.18% | -613.66% | -197.59% | -121.00% | 2.38% | 22.30% | 26.85% | 39.04% | 14.57% | -2.45% | -38.60% | -169.45% | -320.18% | - | - | - | - | - | - |
Profit Margin | -3537.73% | -2895.05% | -565.48% | -168.17% | -92.30% | 14.39% | 31.14% | 25.53% | 43.63% | 14.42% | -5.18% | -24.98% | -189.66% | -315.20% | - | - | - | - | - | - |
Free Cash Flow Margin | -2867.07% | -2294.20% | -509.63% | -210.98% | -159.24% | -33.68% | -21.21% | -8.11% | -7.73% | -57.65% | 104.01% | 127.53% | 250.55% | 501.36% | - | - | - | - | - | - |
EBITDA | -170.86 | -172.56 | -151.9 | -117.36 | -92.26 | 7.89 | 50.78 | 61.3 | 96.87 | 26.97 | -0.32 | -31.02 | -71.28 | -78.83 | -95.35 | -88.4 | -77.04 | -63.58 | -50.01 | -40.47 |
EBITDA Margin | - | - | - | -190.76% | -116.08% | 4.58% | 24.09% | 28.48% | 40.46% | 16.56% | -0.25% | -35.58% | -164.13% | - | - | - | - | - | - | - |
D&A For EBITDA | 3.76 | 3.96 | 4.1 | 4.2 | 3.91 | 3.79 | 3.77 | 3.52 | 3.41 | 3.23 | 2.84 | 2.63 | 2.31 | 2.05 | 1.9 | 1.73 | 1.52 | 1.31 | 1.12 | 0.85 |
EBIT | -174.63 | -176.51 | -156 | -121.56 | -96.16 | 4.11 | 47.01 | 57.78 | 93.45 | 23.73 | -3.16 | -33.65 | -73.59 | -80.88 | -97.25 | -90.13 | -78.56 | -64.89 | -51.13 | -41.32 |
EBIT Margin | - | - | - | -197.59% | -121.00% | 2.38% | 22.30% | 26.85% | 39.04% | 14.57% | -2.45% | -38.60% | -169.45% | - | - | - | - | - | - | - |
Effective Tax Rate | - | - | - | - | - | - | 1.29% | 28.09% | 5.37% | 42.02% | 155.45% | - | - | - | - | - | - | - | - | - |